Literature DB >> 24890618

Prognostic significance of body mass index before treatment for head and neck cancer.

Yukinori Takenaka1, Norihiko Takemoto1, Susumu Nakahara1, Yoshifumi Yamamoto1, Toshimichi Yasui1, Atshushi Hanamoto1, Takahito Fukusumi1, Takahiro Michiba1, Hironori Cho1, Masashi Yamamoto1, Hidenori Inohara1.   

Abstract

BACKGROUND: Patients with head and neck cancer frequently experience malnutrition. The purpose of this study was to examine the impact of nutritional status on prognosis and its association with treatment modalities.
METHODS: This retrospective study included 706 patients with head and neck cancer diagnosed between 2004 and 2012. The effects of pretreatment body mass index (BMI) on overall survival were analyzed using the Kaplan-Meier method and Cox regression model.
RESULTS: BMI ranged from 11.6 to 38.0 kg/m2 (median, 21.5) and was a prognostic factor for survival, independent of primary site, and tumor stage. The 5-year survival rates for underweight, normal, and overweight groups were 32.2%, 62.7%, and 73.5%, respectively. The hazard ratios of BMI in the surgery, chemoradiation, and radiation groups were 0.95, 0.91, and 0.79, respectively, and the latter two were statistically significant.
CONCLUSION: The impact of BMI is determined by the types of cancer treatment. Pretreatment BMI should be considered while deciding treatment.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  body mass index, nutrition; head and neck; prognosis; squamous cell carcinoma

Mesh:

Year:  2014        PMID: 24890618     DOI: 10.1002/hed.23785

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  15 in total

Review 1.  Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy.

Authors:  Mojca Gorenc; Nada Rotovnik Kozjek; Primož Strojan
Journal:  Rep Pract Oncol Radiother       Date:  2015-03-29

2.  Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.

Authors:  Kenji Nakano; Yasuyoshi Sato; Takashi Toshiyasu; Yukiko Sato; Lina Inagaki; Junichi Tomomatsu; Toru Sasaki; Wataru Shimbashi; Hirofumi Fukushima; Hiroyuki Yonekawa; Hiroki Mitani; Kazuyoshi Kawabata; Shunji Takahashi
Journal:  Mol Clin Oncol       Date:  2015-11-25

3.  A Bayesian Sensitivity Analysis to Partition Body Mass Index Into Components of Body Composition: An Application to Head and Neck Cancer Survival.

Authors:  Patrick T Bradshaw; Jose P Zevallos; Kathy Wisniewski; Andrew F Olshan
Journal:  Am J Epidemiol       Date:  2019-11-01       Impact factor: 4.897

4.  Development of a new outcome prediction model for Chinese patients with penile squamous cell carcinoma based on preoperative serum C-reactive protein, body mass index, and standard pathological risk factors: the TNCB score group system.

Authors:  Zai-Shang Li; Peng Chen; Kai Yao; Bin Wang; Jing Li; Qi-Wu Mi; Xiao-Feng Chen; Qi Zhao; Yong-Hong Li; Jie-Ping Chen; Chuang-Zhong Deng; Yun-Lin Ye; Ming-Zhu Zhong; Zhuo-Wei Liu; Zi-Ke Qin; Xiang-Tian Lin; Wei-Cong Liang; Hui Han; Fang-Jian Zhou
Journal:  Oncotarget       Date:  2016-04-12

5.  Body mass index as a prognostic factor in patients with extranodal natural killer/T-cell lymphoma, nasal type.

Authors:  Jie Liu; Yao-Tiao Deng; Li Zhang; Na Li; Ming Jiang; Li-Qun Zou; Yu Jiang
Journal:  Oncotarget       Date:  2016-11-22

6.  Prognostic significance of combined pretreatment lymphocyte counts and body mass index in patients with head and neck cancer treated with radiation therapy.

Authors:  Yao-Yu Wu; Kai-Ping Chang; Chien-Yu Lin; Ping-Ching Pai; Hung-Ming Wang; Cheng-Lung Hsu; Chun-Ta Liao; Tzu-Chen Yen; Tuan-Jen Fang; Shiang-Fu Huang; Chung-Jan Kang; Ku-Hao Fang; Wan-Ni Lin; Yu-Chien Wang; Li-Jen Hsin; Ngan-Ming Tsang
Journal:  Cancer Med       Date:  2018-05-23       Impact factor: 4.452

7.  Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma.

Authors:  Zhao-Qu Li; Lan Zou; Tian-Run Liu; An-Kui Yang
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

8.  Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival.

Authors:  Kambiz Novin; Ahmad Ameri; Saba Faraji; Peyman Torbati; Nafiseh Mortazavi
Journal:  Iran J Cancer Prev       Date:  2015-10-27

9.  Bioelectrical phase angle at diagnosis as a prognostic factor for survival in advanced head and neck cancer.

Authors:  Lars Axelsson; Ewa Silander; Ingvar Bosaeus; Eva Hammerlid
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-25       Impact factor: 2.503

10.  Obesity as an independent predictive factor for pathologic complete response after neoadjuvant chemoradiation in rectal cancer.

Authors:  Soo Young Lee; Chang Hyun Kim; Young Jin Kim; Han Deok Kwak; Jae Kyun Ju; Hyeong Rok Kim
Journal:  Ann Surg Treat Res       Date:  2018-02-26       Impact factor: 1.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.